Series C startups in Massachusetts, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Delix Therapeutics | Boston | Series C | $100.0M | 2026-11-09 |
| ZwitterCo | Woburn | Series C | $58.4M | 2026-10-22 |
| ASI | Boston | Series C | $325.0M | 2026-10-20 |
| Ledgebrook | Boston | Series C | $200.0M | 2026-10-07 |
| Ratio Therapeutics | Boston | Series C | $70.0M | 2026-07-31 |
| Hyperlight | Cambridge | Series C | $80.0M | 2026-06-18 |
| Triveni Bio | Watertown | Series C | $65.0M | 2026-06-17 |
| InStride Health | Boston | Series C | $30.0M | 2026-06-15 |
8 rows of the CSV in 5 of its 18 columns.
- The 255 series c startups in Massachusetts, United States have raised $20.8B in total.
- 21 of them closed their most recent round in the last 12 months, $1.7B combined.
- The largest of those rounds is ASI's $325.0M Series C, dated October 2026.
- The most recent is Delix Therapeutics' $100.0M Series C on 9 November 2026.
- North Bridge Venture Partners & Growth Equity is an investor in 11 of them, more than any other fund.
- Software is the most common sector, with 125 companies (49%).
- 4% were founded in 2020 or later; the median founding year is 2009.
- The most common team size is 11 to 50 employees (31% of companies with a recorded size).
- 3 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 255| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| ASI | ASI develops AI software for managing complex physical operations in aviation, defense, energy, and logistics. | Artificial intelligence | Boston | Series C | $325.0M | 2026-10-20 | $359.4M | Andreessen Horowitz, Village Global, Gradient +2 | 101 to 250 | 2018 |
| Ledgebrook | Ledgebrook provides excess and surplus insurance solutions through wholesale brokers. | Artificial intelligence | Boston | Series C | $200.0M | 2026-10-07 | $314.8M | Brand Foundry Ventures, Markd, American Family Ventures +2 | 251 to 500 | 2021 |
| Ratio Therapeutics | Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. | Biotech | Boston | Series C | $70.0M | 2026-07-31 | $160.0M | Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments | 11 to 50 | 2021 |
| Hyperlight | Hyperlight produces thin-film lithium niobate photonic integrated circuits. | Hardware | Cambridge | Series C | $80.0M | 2026-06-18 | $117.0M | Summit Partners, Foothill Ventures, The Engine +1 | 11 to 50 | 2018 |
| Triveni Bio | Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. | Biotech | Watertown | Series C | $65.0M | 2026-06-17 | $272.0M | Polaris Partners, OrbiMed, Alexandria Venture Investments +2 | 11 to 50 | 2019 |
| InStride Health | InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. | Health care | Boston | Series C | $30.0M | 2026-06-15 | $86.0M | General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 | 251 to 500 | 2021 |
| CereVasc | CereVasc develops a minimally invasive treatment for communicating hydrocephalus. | Biotech | Charlestown | Series C | $85.0M | 2026-06-04 | $199.0M | Perceptive Advisors, Bain Capital Life Sciences, ATON Partners | 11 to 50 | 2014 |
| Cerevance | Cerevance develops novel therapeutics for neurological diseases. | Biotech | Boston | Series C | $20.0M | 2026-05-12 | $209.5M | Google Ventures, Casdin Capital, Foresite Capital +1 | 51 to 100 | 2016 |
| Iterative Health | Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. | Artificial intelligence | Cambridge | Series C | $77.0M | 2026-04-30 | $268.6M | Plug and Play, Alumni Ventures, Insight Partners +1 | 251 to 500 | 2017 |
| AcuityMD | AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. | Artificial intelligence | Boston | Series C | $80.0M | 2026-04-21 | $163.0M | Redpoint, Benchmark, ICONIQ Growth +2 | 251 to 500 | 2019 |
| Terrestrial Bio | Terrestrial Bio develops biomedical innovations aimed at improving access to vaccines. | Biotech | Cambridge | Series C | $50.0M | 2026-03-26 | $180.9M | RA Capital Management, National Institutes of Health, The Engine | 11 to 50 | 2012 |
| Cognito Therapeutics | Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. | Biotech | Cambridge | Series C | $105.0M | 2026-03-05 | $321.8M | Morningside, FoundersX Ventures, IAG Capital Partners +1 | 11 to 50 | 2016 |
| Tive | Tive develops hardware and software that tracks the conditions of shipments. | Software | Boston | Series C | $20.0M | 2026-01-02 | $141.9M | Techstars, Plug and Play, Qualcomm Ventures +2 | 101 to 250 | 2015 |
| CloudZero | CloudZero analyzes and manages cloud spending for organizations. | Artificial intelligence | Boston | Series C | $56.0M | 2025-05-28 | $119.1M | Matrix, Underscore VC, Threshold +1 | 101 to 250 | 2016 |
| CollegeVine | CollegeVine deploys AI agents that take over administrative work across higher education. | Artificial intelligence | Boston | Series C | $24.0M | 2025-01-01 | $66.7M | Silicon Valley Bank, Fidelity, Morningside +2 | 51 to 100 | 2016 |
| REsurety | REsurety provides risk management and software products to clean energy buyers and sellers. | Energy | Boston | Series C | $32.0M | 2024-10-15 | $49.3M | Citi, LaunchCapital, S2G Investments +2 | 51 to 100 | 2012 |
| Smartcat | Smartcat connects businesses and translators on one platform for continuous translation delivery. | Software | Cambridge | Series C | $43.0M | 2024-09-10 | $71.9M | FJ Labs, Matrix, AltaIR Capital +2 | 251 to 500 | 2016 |
| NanoHive Medical | NanoHive Medical makes 3D-printed spinal interbody implants and instruments. | Health care | Woburn | Series C | $7.0M | 2024-08-05 | $7.0M | Sky Ventures Group | 11 to 50 | 2014 |
| Sionna Therapeutics | Sionna Therapeutics develops small molecule therapies for treating cystic fibrosis. | Biotech | Natick | Series C | $182.0M | 2024-03-06 | $292.0M | RA Capital Management, OrbiMed, T. Rowe Price +2 | 11 to 50 | 2018 |
| Overjet | Overjet is a software company that offers an AI platform for dentistry and educates patients. | Artificial intelligence | Boston | Series C | $53.2M | 2024-03-05 | Insight Partners, General Catalyst, Liquid 2 Ventures +2 | 101 to 250 | 2018 | |
| Accent Therapeutics | Accent Therapeutics is a biopharmaceutical company. | Biotech | Lexington | Series C | $75.0M | 2024-01-23 | $178.0M | Google Ventures, Mirae Asset Venture Investment, Bristol-Myers Squibb +2 | 11 to 50 | 2017 |
| Access Vascular | Access Vascular develops novel hydrophilic-based medical devices that improve venous access. | Health care | Bedford | Series C | $22.0M | 2023-10-31 | $57.1M | MedTech Innovator, TVM Capital Life Science, AngelMD | 11 to 50 | 2015 |
| Nobl9 | Nobl9 is a platform that connects reliability metrics to business goals through service level objectives. | Software | Waltham | Series C | $15.8M | 2023-01-31 | $44.3M | Battery Ventures, CRV, Cisco Investments +1 | 51 to 100 | 2019 |
| Owl Labs | Owl Labs makes video conferencing devices that create immersive collaboration experiences for remote teams. | Artificial intelligence | Somerville | Series C | $25.0M | 2022-11-14 | $47.3M | Matrix, Spark Capital, Bantam Group +1 | 101 to 250 | 2014 |
| Own Up | Own Up helps consumers shop for a mortgage. | Fintech | Boston | Series C | $25.5M | 2022-08-30 | $49.7M | Techstars, Alumni Ventures, MassChallenge +2 | 11 to 50 | 2016 |
| LogRocket | LogRocket provides frontend monitoring and product analytics that capture user experience data. | Software | Boston | Series C | $25.0M | 2022-06-21 | $55.0M | Battery Ventures, Matrix, Delta-v Capital | 101 to 250 | 2016 |
| IntelyCare Unicorn | IntelyCare provides a workforce management platform for healthcare staffing, scheduling, and training. | Health care | Quincy | Series C | $115.0M | 2022-04-06 | $170.8M | LRVHealth, Eastward Capital Partners, Longitude Capital +2 | 251 to 500 | 2014 |
| LinkSquares | LinkSquares provides an AI-powered contract lifecycle management platform for in-house legal teams. | Artificial intelligence | Boston | Series C | $100.0M | 2022-04-04 | $161.5M | Sorenson Capital, MassMutual Ventures, Cerity Partners Ventures +1 | 101 to 250 | 2015 |
| ConcertAI Unicorn | ConcertAI sells AI-powered SaaS data tools for medical research in oncology. | Artificial intelligence | Cambridge | Series C | $150.0M | 2022-03-29 | $300.0M | Maverick Ventures, Sixth Street, Declaration Partners +2 | 1,001 to 5,000 | 2018 |
Table 1. Series C startups in Massachusetts, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 255.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ASI | ASI develops AI software for managing complex physical operations in aviation, defense, energy, and logistics. | Artificial intelligence | Boston | Series C | $325.0M | 2026-10-20 | $359.4M | Andreessen Horowitz, Village Global, Gradient +2 | 101 to 250 | 2018 |
| 2 | Ledgebrook | Ledgebrook provides excess and surplus insurance solutions through wholesale brokers. | Artificial intelligence | Boston | Series C | $200.0M | 2026-10-07 | $314.8M | Brand Foundry Ventures, Markd, American Family Ventures +2 | 251 to 500 | 2021 |
| 3 | Cognito Therapeutics | Cognito Therapeutics develops neurotechnology therapies that stimulate brain activity to treat neurodegenerative diseases. | Biotech | Cambridge | Series C | $105.0M | 2026-03-05 | $321.8M | Morningside, FoundersX Ventures, IAG Capital Partners +1 | 11 to 50 | 2016 |
| 4 | Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| 5 | CereVasc | CereVasc develops a minimally invasive treatment for communicating hydrocephalus. | Biotech | Charlestown | Series C | $85.0M | 2026-06-04 | $199.0M | Perceptive Advisors, Bain Capital Life Sciences, ATON Partners | 11 to 50 | 2014 |
| 6 | Hyperlight | Hyperlight produces thin-film lithium niobate photonic integrated circuits. | Hardware | Cambridge | Series C | $80.0M | 2026-06-18 | $117.0M | Summit Partners, Foothill Ventures, The Engine +1 | 11 to 50 | 2018 |
| 7 | AcuityMD | AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. | Artificial intelligence | Boston | Series C | $80.0M | 2026-04-21 | $163.0M | Redpoint, Benchmark, ICONIQ Growth +2 | 251 to 500 | 2019 |
| 8 | Iterative Health | Iterative Health develops technology to improve patient access to healthcare across different socioeconomic and geographic areas. | Artificial intelligence | Cambridge | Series C | $77.0M | 2026-04-30 | $268.6M | Plug and Play, Alumni Ventures, Insight Partners +1 | 251 to 500 | 2017 |
| 9 | Ratio Therapeutics | Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. | Biotech | Boston | Series C | $70.0M | 2026-07-31 | $160.0M | Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments | 11 to 50 | 2021 |
| 10 | Triveni Bio | Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. | Biotech | Watertown | Series C | $65.0M | 2026-06-17 | $272.0M | Polaris Partners, OrbiMed, Alexandria Venture Investments +2 | 11 to 50 | 2019 |
Table 2. Series C startups in Massachusetts, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | North Bridge Venture Partners & Growth Equity | Venture capital firm | Wellesley, United States | 11 | 4% | ||
| 2 | General Catalyst | Venture capital firm | San Francisco, United States | 10 | 4% | 1 | InStride Health |
| 3 | Insight Partners | Private equity firm | New York, United States | 8 | 3% | 1 | Iterative Health |
| 4 | Matrix | Venture capital firm | Cambridge, United States | 8 | 3% | ||
| 5 | Polaris Partners | Private equity firm | Boston, United States | 7 | 3% | 1 | Triveni Bio |
| 6 | Techstars | Startup accelerator | New York, United States | 7 | 3% | 1 | Tive |
| 7 | CRV | Venture capital firm | San Francisco, United States | 7 | 3% | ||
| 8 | Bessemer Venture Partners | Venture capital firm | San Francisco, United States | 7 | 3% | ||
| 9 | .406 Ventures | Venture capital firm | Boston, United States | 5 | 2% | 1 | InStride Health |
| 10 | Alumni Ventures | Angel group | Manchester, United States | 5 | 2% | 1 | Iterative Health |
| 11 | Bain Capital Ventures | Venture capital firm | San Francisco, United States | 5 | 2% | ||
| 12 | RA Capital Management | Startup incubator | Boston, United States | 4 | 2% | 2 | Delix Therapeutics, Terrestrial Bio |
| 13 | Google Ventures | Corporate venture arm | San Francisco, United States | 4 | 2% | 1 | Cerevance |
| 14 | Battery Ventures | Venture capital firm | Boston, United States | 4 | 2% | ||
| 15 | Spark Capital | Venture capital firm | San Francisco, United States | 4 | 2% |
Table 3. Series C startups in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 125 | 49% | $8.7B |
| Health care | 97 | 38% | $11.3B |
| Biotech | 70 | 27% | $10.5B |
| Hardware | 51 | 20% | $2.9B |
| Artificial intelligence | 27 | 11% | $4.1B |
| Commerce | 19 | 7% | $823.5M |
| Fintech | 14 | 5% | $773.5M |
| Cybersecurity | 13 | 5% | $618.1M |
| Education | 10 | 4% | $243.4M |
| Energy | 6 | 2% | $420.1M |
Table 4. Series C startups in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 255 | 100% | $23.0M |
Table 5. Series C startups in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Series C startups in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 10% | $115.0M |
| October 2026 | 4 | 19% | $693.4M |
| September 2026 | 1 | 5% | $6.0M |
| July 2026 | 2 | 10% | $107.0M |
| June 2026 | 5 | 24% | $345.0M |
| May 2026 | 1 | 5% | $20.0M |
| April 2026 | 3 | 14% | $257.0M |
| March 2026 | 2 | 10% | $155.0M |
| January 2026 | 1 | 5% | $20.0M |
Table 7. Series C startups in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 21 | 8% | $1.7B |
| 2025 | 16 | 6% | $1.0B |
| 2024 | 12 | 5% | $872.5M |
| 2023 | 8 | 3% | $331.3M |
| 2022 | 19 | 7% | $1.5B |
| 2021 | 19 | 7% | $976.0M |
Table 8. Series C startups in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 9 | 4% |
| 2015 to 2019 | 64 | 25% |
| 2010 to 2014 | 48 | 19% |
| Before 2010 | 133 | 52% |
Table 9. Series C startups in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 14 | 6% |
| 11 to 50 | 75 | 31% |
| 51 to 100 | 69 | 28% |
| 101 to 250 | 59 | 24% |
| 251 to 500 | 16 | 7% |
| 501 to 1,000 | 7 | 3% |
| 1,001 to 5,000 | 5 | 2% |
Table 10. Series C startups in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series C and its headquarters is in Massachusetts, United States. On 16 November 2026 that is 255 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 255 rows: 9 have no round amount, 0 no city and 36 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series c startups in Massachusetts, United States are on the list?
- 255, in the file dated 16 November 2026. 21 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 255 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.